Muhammad Aamir Latif
Clinical trials sponsored by Muhammad Aamir Latif, explained in plain language.
-
Head-to-Head: which drug better shields kids from migraines?
Disease control Recruiting nowThis study aims to find out which of two existing drugs, flunarizine or propranolol, works better to prevent migraines in children. It will involve 44 kids aged 8 to 15 who have frequent migraines. Researchers will measure how much each drug reduces the children's headache-relate…
Phase: NA • Sponsor: Muhammad Aamir Latif • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Can a simple supplement help fragile preemies breathe and grow?
Disease control Recruiting nowThis study is testing whether giving L-Carnitine, a natural substance, helps premature babies with severe breathing problems (RDS). Researchers want to see if it helps these fragile newborns gain weight and survive until they can go home. They are enrolling 160 preterm babies to …
Phase: NA • Sponsor: Muhammad Aamir Latif • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Coffee for preemies? study tests caffeine to shield tiny kidneys
Prevention Recruiting nowThis study is testing whether giving caffeine very early to extremely premature babies can help prevent sudden kidney injury. Researchers will compare caffeine treatment to standard supportive care in 236 newborns born before 32 weeks. The goal is to see if caffeine reduces kidne…
Phase: NA • Sponsor: Muhammad Aamir Latif • Aim: Prevention
Last updated Mar 27, 2026 12:37 UTC
-
New study tests supplements to ease autism symptoms in kids
Symptom relief Recruiting nowThis study compares two supplement approaches—Vita 6 versus zinc—when used alongside standard behavioral therapy to help manage autism symptoms in children aged 3-14. Researchers want to see which option is more effective and safer at reducing symptom severity. The trial involves…
Phase: NA • Sponsor: Muhammad Aamir Latif • Aim: Symptom relief
Last updated Mar 30, 2026 14:30 UTC